These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 2404695)

  • 1. Molecular modelling of C3 and its ligands.
    Sim RB; Perkins SJ
    Curr Top Microbiol Immunol; 1990; 153():209-22. PubMed ID: 2404695
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative modeling of proteins in the complement pathway.
    Greer J; Mollison KW; Carter GW; Zuiderweg ER
    Prog Clin Biol Res; 1989; 289():385-97. PubMed ID: 2786214
    [No Abstract]   [Full Text] [Related]  

  • 3. Identification of the C3b binding site in a recombinant vWF-A domain of complement factor B by surface-enhanced laser desorption-ionisation affinity mass spectrometry and homology modelling: implications for the activity of factor B.
    Hinshelwood J; Spencer DI; Edwards YJ; Perkins SJ
    J Mol Biol; 1999 Nov; 294(2):587-99. PubMed ID: 10610782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conservation of structural and functional domains in complement component C3 of Xenopus and mammals.
    Grossberger D; Marcuz A; Du Pasquier L; Lambris JD
    Proc Natl Acad Sci U S A; 1989 Feb; 86(4):1323-7. PubMed ID: 2919181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular basis of C-reactive protein binding and modulation of complement activation by factor H-related protein 4.
    Hebecker M; Okemefuna AI; Perkins SJ; Mihlan M; Huber-Lang M; Józsi M
    Mol Immunol; 2010 Mar; 47(6):1347-55. PubMed ID: 20042240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active sites in complement components C5 and C3 identified by proximity to indels in the C3/4/5 protein family.
    Low PJ; Ai R; Ogata RT
    J Immunol; 1999 Jun; 162(11):6580-8. PubMed ID: 10352274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleotide and deduced amino acid sequence of rat complement C3.
    Misumi Y; Sohda M; Ikehara Y
    Nucleic Acids Res; 1990 Apr; 18(8):2178. PubMed ID: 2336397
    [No Abstract]   [Full Text] [Related]  

  • 8. The covalent interaction of C3 with IgG immune complexes.
    Vivanco F; Muñoz E; Vidarte L; Pastor C
    Mol Immunol; 1999; 36(13-14):843-52. PubMed ID: 10698338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A complement C3 fragment equivalent to mammalian C3d from the common carp (Cyprinus carpio): generation in serum after activation of the alternative pathway and detection of its receptor on the lymphocyte surface.
    Nakao M; Miura C; Itoh S; Nakahara M; Okumura K; Mutsuro J; Yano T
    Fish Shellfish Immunol; 2004 Feb; 16(2):139-49. PubMed ID: 15123318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple forms of complement C3 in trout that differ in binding to complement activators.
    Sunyer JO; Zarkadis IK; Sahu A; Lambris JD
    Proc Natl Acad Sci U S A; 1996 Aug; 93(16):8546-51. PubMed ID: 8710907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation and characterization of the third complement component of axolotl (Ambystoma mexicanum).
    Avila D; Lambris JD
    Comp Biochem Physiol B; 1990; 95(4):839-45. PubMed ID: 2344737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular aspects of C3 interactions and structural/functional analysis of C3 from different species.
    Becherer JD; Alsenz J; Lambris JD
    Curr Top Microbiol Immunol; 1990; 153():45-72. PubMed ID: 2404697
    [No Abstract]   [Full Text] [Related]  

  • 13. (HX)n repeats: a pH-controlled protein-protein interaction motif of eukaryotic transcription factors?
    Janknecht R; Sander C; Pongs O
    FEBS Lett; 1991 Dec; 295(1-3):1-2. PubMed ID: 1765137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active sites in complement component C3 mapped by mutations at indels.
    Ogata RT; Ai R; Low PJ
    J Immunol; 1998 Nov; 161(9):4785-94. PubMed ID: 9794410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Third component of trout complement. cDNA cloning and conservation of functional sites.
    Lambris JD; Lao Z; Pang J; Alsenz J
    J Immunol; 1993 Dec; 151(11):6123-34. PubMed ID: 8245455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homology model of the CB1 cannabinoid receptor: sites critical for nonclassical cannabinoid agonist interaction.
    Shim JY; Welsh WJ; Howlett AC
    Biopolymers; 2003; 71(2):169-89. PubMed ID: 12767117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions of human complement component C3 with factor B and with complement receptors type 1 (CR1, CD35) and type 3 (CR3, CD11b/CD18) involve an acidic sequence at the N-terminus of C3 alpha'-chain.
    Taniguchi-Sidle A; Isenman DE
    J Immunol; 1994 Dec; 153(11):5285-302. PubMed ID: 7963581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homozygous hereditary C3 deficiency due to a partial gene deletion.
    Botto M; Fong KY; So AK; Barlow R; Routier R; Morley BJ; Walport MJ
    Proc Natl Acad Sci U S A; 1992 Jun; 89(11):4957-61. PubMed ID: 1350678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineering of human complement component C3 for catalytic inhibition of complement.
    Kölln J; Bredehorst R; Spillner E
    Immunol Lett; 2005 Apr; 98(1):49-56. PubMed ID: 15790508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conformational complexity of complement component C3.
    Janssen BJ; Gros P
    Adv Exp Med Biol; 2006; 586():291-312. PubMed ID: 16893080
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.